Stay updated on Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.

Latest updates to the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.5 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.SummaryDifference0.1%
- Check19 days agoChange DetectedA service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.6%
- Check26 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.7%
- Check33 days agoNo Change Detected
- Check41 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.6%
- Check55 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check62 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
Stay in the know with updates to Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.